These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6248790)

  • 1. Lack of M-MuSV tumour regression associated with T lymphocyte tolerance.
    Chieco-Bianchi L; Collavo D; Zanovell P; De Rossi A; Davies AJ
    Nature; 1980 Jun; 285(5767):667-8. PubMed ID: 6248790
    [No Abstract]   [Full Text] [Related]  

  • 2. Immune reactivity in the Moloney strain of murine sarcoma virus oncogenesis: requirement of thymus-derived lymphocytes for in vivo protection.
    Collavo D; Colombatti A; Biasi G; Chieco-Bianchi L; Davies AJ
    J Natl Cancer Inst; 1976 Mar; 56(3):603-8. PubMed ID: 176399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Appearance and distribution of virally determined antigens in lymphoid organs of mice during leukemogenesis by Moloney leukemia virus.
    Asjö B; Fenyö EM; Spira J; Klein G
    Leuk Res; 1980; 4(1):89-103. PubMed ID: 7412358
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunological study of two stocks of Moloney sarcoma virus producing regressor and progressor tumors in C57BL/6 mice.
    Takeichi N; Boone CW; Holden HT; Herberman RB
    Int J Cancer; 1978 Jan; 21(1):78-84. PubMed ID: 203543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors.
    Collavo D; Ronchese F; Zanovello P; Biasi G; Chieco-Bianchi L
    J Immunol; 1982 Feb; 128(2):774-9. PubMed ID: 6459385
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunologic tolerance to antigens associated with murine leukemia viruses: T-cell unresponsiveness?
    Chieco-Bianchi L; Sendo F; Aoki T; Barrera OL
    J Natl Cancer Inst; 1974 Apr; 52(4):1345-50. PubMed ID: 4133203
    [No Abstract]   [Full Text] [Related]  

  • 7. T lymphocyte tolerance and early appearance of virus-induced cell surface antigens in Moloney-murine leukemia virus neonatally injected mice.
    Collavo D; Zanovello P; Biasi G; Chieco-Bianchi L
    J Immunol; 1981 Jan; 126(1):187-93. PubMed ID: 6969741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of Toxoplasma on manifestations of Moloney virus infections.
    McLeod R; Estes RG; Cohen H
    Trans R Soc Trop Med Hyg; 1985; 79(6):781-7. PubMed ID: 2938310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moloney murine leukemia virus tolerance in anti-CD4 monoclonal antibody-treated adult mice.
    Biasi G; Facchinetti A; Panozzo M; Zanovello P; Chieco-Bianchi L; Collavo D
    J Immunol; 1991 Oct; 147(7):2284-9. PubMed ID: 1833453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major histocompatibility-restricted cytolytic T-lymphocyte precursors from the thymus of in vivo primed mice: increased frequency and resistance to anti-Lyt-2 antibody inhibition.
    Ceredig R
    Curr Top Microbiol Immunol; 1986; 126():27-33. PubMed ID: 3013506
    [No Abstract]   [Full Text] [Related]  

  • 11. T lymphocyte requirement for MSV tumour prevention or regression.
    Collavo D; Colombatti A; Chieco-Bianchi L
    Nature; 1974 May; 249(453):169-70. PubMed ID: 4545519
    [No Abstract]   [Full Text] [Related]  

  • 12. Virus-specific T cell response prevents lymphoma development in mice infected by intrathymic inoculation of Moloney leukaemia virus (M-MuLV).
    Zanovello P; Collavo D; Ronchese F; De Rossi A; Biasi G; Chieco-Bianchi L
    Immunology; 1984 Jan; 51(1):9-16. PubMed ID: 6228521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-enhancing suppressor activator T cells in spleens and thymuses of tumor immune mice.
    Hellström I; Hellström KE; Bernstein ID
    Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5294-8. PubMed ID: 315560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization against primary, transplanted and spontaneous murine leukaemia using a live Moloney sarcoma virus vaccine.
    Mayer AM; Basombrio MA; Pasqualini CD
    Br J Cancer; 1980 Jun; 41(6):966-75. PubMed ID: 6252923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic control of sensitivity to moloney leukemia virus in mice. VI. Involvement of virus-specific T helper cells collaborating with B cells.
    Boyer B; Debré P; Seman M; Zilberfarb V; Lévy JP
    Eur J Immunol; 1982 Aug; 12(8):692-7. PubMed ID: 6216112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune complexes in mice infected neonatally with Moloney leukaemogenic and murine sarcoma viruses.
    Hirsch MS; Allison AC; Harvey JJ
    Nature; 1969 Aug; 223(5207):739-40. PubMed ID: 4308421
    [No Abstract]   [Full Text] [Related]  

  • 17. Secondary in vitro generation of cytolytic T-lymphocytes (CTL's) in the murine sarcoma virus system. Virus-specific CTL induction across the H-2 barrier.
    Collavo D; Parenti A; Biasi G; Chieco-Bianchi L; Colombatti A
    J Natl Cancer Inst; 1978 Sep; 61(3):885-90. PubMed ID: 80457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulatory effect of immunization on tumor induction by Moloney murine sarcoma virus.
    Murasko DM; Prehn RT
    J Natl Cancer Inst; 1978 Nov; 61(5):1323-7. PubMed ID: 213613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody formation, latency and leukemia: infection with Moloney virus.
    Cremer NE; Taylor DO; Hagens SJ
    J Immunol; 1966 Mar; 96(3):495-508. PubMed ID: 5932581
    [No Abstract]   [Full Text] [Related]  

  • 20. [Resistance of AKR mice to the oncogenic action of Moloney murine sarcoma virus].
    Tsysina EN; Irlin IS
    Biull Eksp Biol Med; 1971 Oct; 72(10):85-8. PubMed ID: 5126159
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.